{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T01:43:49Z","timestamp":1773107029850,"version":"3.50.1"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T00:00:00Z","timestamp":1238716800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00428-009-0766-2","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T05:43:55Z","timestamp":1238651035000},"page":"481-495","source":"Crossref","is-referenced-by-count":42,"title":["Mitochondria and cancer"],"prefix":"10.1007","volume":"454","author":[{"given":"Valdemar","family":"M\u00e1ximo","sequence":"first","affiliation":[]},{"given":"Jorge","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Paula","family":"Soares","sequence":"additional","affiliation":[]},{"given":"Manuel","family":"Sobrinho-Sim\u00f5es","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,4,3]]},"reference":[{"key":"766_CR1","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On the origin of cancer cells. Science 123:309\u2013314","journal-title":"Science"},{"key":"766_CR2","volume-title":"The metabolism of tumours","author":"O Warburg","year":"1930","unstructured":"Warburg O (1930) The metabolism of tumours. London Constable, London"},{"key":"766_CR3","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E (1927) The metabolism of tumors in the body. J Gen Physiol 8:519\u2013530","journal-title":"J Gen Physiol"},{"key":"766_CR4","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal BE, Ferrell RE, Willett-Brozick JE et al (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848\u2013851","journal-title":"Science"},{"key":"766_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti D, Latif F, Dallol A et al (2001) Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 69:49\u201354","journal-title":"Am J Hum Genet"},{"key":"766_CR6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268\u2013270","journal-title":"Nat Genet"},{"key":"766_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.2005.067041","volume":"77","author":"R Horvath","year":"2006","unstructured":"Horvath R, Abicht A, Holinski-Feder E et al (2006) Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry 77:74\u201376","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"766_CR8","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1126\/science.283.5407.1482","volume":"283","author":"DC Wallace","year":"1999","unstructured":"Wallace DC (1999) Mitochondrial diseases in man and mouse. Science 283:1482\u20131488","journal-title":"Science"},{"key":"766_CR9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359\u2013407","journal-title":"Annu Rev Genet"},{"key":"766_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1148\/radiol.2312021185","volume":"231","author":"EM Rohren","year":"2004","unstructured":"Rohren EM, Turkington TG, Coleman RE (2004) Clinical applications of PET in oncology. Radiology 231:305\u2013332","journal-title":"Radiology"},{"key":"766_CR11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0016-5085(00)70169-7","volume":"118","author":"W Habano","year":"2000","unstructured":"Habano W, Sugai T, Nakamura SI et al (2000) Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 118:835\u2013841","journal-title":"Gastroenterology"},{"key":"766_CR12","first-page":"4231","volume":"60","author":"SM Richard","year":"2000","unstructured":"Richard SM, Bailliet G, Paez GL et al (2000) Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res 60:4231\u20134237","journal-title":"Cancer Res"},{"key":"766_CR13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/gcc.1175","volume":"32","author":"V Maximo","year":"2001","unstructured":"Maximo V, Soares P, Seruca R et al (2001) Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer 32:136\u2013143","journal-title":"Genes Chromosomes Cancer"},{"key":"766_CR14","first-page":"1105","volume":"147","author":"LJ Burgart","year":"1995","unstructured":"Burgart LJ, Zheng J, Shu Q et al (1995) Somatic mitochondrial mutation in gastric cancer. Am J Pathol 147:1105\u20131111","journal-title":"Am J Pathol"},{"key":"766_CR15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/(SICI)1097-0215(19991126)83:5<625::AID-IJC10>3.0.CO;2-N","volume":"83","author":"W Habano","year":"1999","unstructured":"Habano W, Sugai T, Yoshida T et al (1999) Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer 83:625\u2013629","journal-title":"Int J Cancer"},{"key":"766_CR16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/3108","volume":"20","author":"K Polyak","year":"1998","unstructured":"Polyak K, Li Y, Zhu H et al (1998) Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet 20:291\u2013293","journal-title":"Nat Genet"},{"key":"766_CR17","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1126\/science.287.5460.2017","volume":"287","author":"MS Fliss","year":"2000","unstructured":"Fliss MS, Usadel H, Caballero OL et al (2000) Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287:2017\u20132019","journal-title":"Science"},{"key":"766_CR18","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1038\/sj.onc.1203537","volume":"19","author":"JJ Yeh","year":"2000","unstructured":"Yeh JJ, Lunetta KL, Van Orsouw NJ et al (2000) Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene 19:2060\u20132066","journal-title":"Oncogene"},{"key":"766_CR19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH634>3.0.CO;2-U","volume":"191","author":"PD Lewis","year":"2000","unstructured":"Lewis PD, Baxter P, Paul GA et al (2000) Detection of damage to the mitochondrial genome in the oncocytic cells of Warthin's tumour. J Pathol 191:274\u2013281","journal-title":"J Pathol"},{"key":"766_CR20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000133706","volume":"66","author":"G Tallini","year":"1994","unstructured":"Tallini G, Ladanyi M, Rosai J et al (1994) Analysis of nuclear and mitochondrial DNA alterations in thyroid and renal oncocytic tumors. Cytogenet Cell Genet 66:253\u2013259","journal-title":"Cytogenet Cell Genet"},{"key":"766_CR21","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0002-9440(10)61132-7","volume":"160","author":"V Maximo","year":"2002","unstructured":"Maximo V, Soares P, Lima J et al (2002) Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am J Pathol 160:1857\u20131865","journal-title":"Am J Pathol"},{"key":"766_CR22","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/sj.onc.1208292","volume":"24","author":"KK Abu-Amero","year":"2005","unstructured":"Abu-Amero KK, Alzahrani AS, Zou M et al (2005) High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene 24:1455\u20131460","journal-title":"Oncogene"},{"key":"766_CR23","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1158\/0008-5472.CAN-06-0171","volume":"66","author":"E Bonora","year":"2006","unstructured":"Bonora E, Porcelli AM, Gasparre G et al (2006) Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. Cancer Res 66:6087\u20136096","journal-title":"Cancer Res"},{"key":"766_CR24","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/carcin\/23.10.1577","volume":"23","author":"HD Lohrer","year":"2002","unstructured":"Lohrer HD, Hieber L, Zitzelsberger H (2002) Differential mutation frequency in mitochondrial DNA from thyroid tumours. Carcinogenesis 23:1577\u20131582","journal-title":"Carcinogenesis"},{"key":"766_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s004280000219","volume":"437","author":"V Maximo","year":"2000","unstructured":"Maximo V, Sobrinho-Simoes M (2000) Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch 437:107\u2013115","journal-title":"Virchows Arch"},{"key":"766_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mito.2005.06.003","volume":"5","author":"V Maximo","year":"2005","unstructured":"Maximo V, Lima J, Soares P et al (2005) Mitochondrial D-loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion 5:333\u2013340","journal-title":"Mitochondrion"},{"key":"766_CR27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1507\/endocrj.51.265","volume":"51","author":"T Rogounovitch","year":"2004","unstructured":"Rogounovitch T, Saenko V, Yamashita S (2004) Mitochondrial DNA and human thyroid diseases. Endocr J 51:265\u2013277","journal-title":"Endocr J"},{"key":"766_CR28","doi-asserted-by":"crossref","first-page":"4920","DOI":"10.1210\/jcem.86.10.7894","volume":"86","author":"F Savagner","year":"2001","unstructured":"Savagner F, Franc B, Guyetant S et al (2001) Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors. J Clin Endocrinol Metab 86:4920\u20134925","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR29","doi-asserted-by":"crossref","first-page":"9001","DOI":"10.1073\/pnas.0703056104","volume":"104","author":"G Gasparre","year":"2007","unstructured":"Gasparre G, Porcelli AM, Bonora E et al (2007) Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors. Proc Natl Acad Sci U S A 104:9001\u20139006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/humu.20870","volume":"30","author":"G Gasparre","year":"2008","unstructured":"Gasparre G, Iommarini L, Porcelli AM et al (2008) An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells. Hum Mutat 30:391\u2013396","journal-title":"Hum Mutat"},{"key":"766_CR31","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1038\/sj.onc.1204646","volume":"20","author":"C Jeronimo","year":"2001","unstructured":"Jeronimo C, Nomoto S, Caballero OL et al (2001) Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene 20:5195\u20135198","journal-title":"Oncogene"},{"key":"766_CR32","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1073\/pnas.0610818104","volume":"104","author":"S Zhou","year":"2007","unstructured":"Zhou S, Kachhap S, Sun W et al (2007) Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc Natl Acad Sci U S A 104:7540\u20137545","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR33","doi-asserted-by":"crossref","unstructured":"Park JS, Sharma LK, Li HZ et al. (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet (in press)","DOI":"10.1093\/hmg\/ddp069"},{"key":"766_CR34","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-0-387-84835-8_11","volume-title":"Mitochondria and cancer","author":"J Lima","year":"2009","unstructured":"Lima J, Maximo V, Soares P et al (2009) Mitochondria and oncocytomas. In: Singh KK, Costello LC (eds) Mitochondria and cancer. Springer, New York, pp 193\u2013209"},{"key":"766_CR35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1081\/CNV-120002155","volume":"20","author":"WC Copeland","year":"2002","unstructured":"Copeland WC, Wachsman JT, Johnson FM et al (2002) Mitochondrial DNA alterations in cancer. Cancer Invest 20:557\u2013569","journal-title":"Cancer Invest"},{"key":"766_CR36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF03194602","volume":"47","author":"AM Czarnecka","year":"2006","unstructured":"Czarnecka AM, Golik P, Bartnik E (2006) Mitochondrial DNA mutations in human neoplasia. J Appl Genet 47:67\u201378","journal-title":"J Appl Genet"},{"key":"766_CR37","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00535-004-1445-3","volume":"39","author":"A Tamori","year":"2004","unstructured":"Tamori A, Nishiguchi S, Nishikawa M et al (2004) Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J Gastroenterol 39:1063\u20131068","journal-title":"J Gastroenterol"},{"key":"766_CR38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1073\/pnas.0408894102","volume":"102","author":"JA Petros","year":"2005","unstructured":"Petros JA, Baumann AK, Ruiz-Pesini E et al (2005) mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A 102:719\u2013724","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR39","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/0008-5472.CAN-04-2012","volume":"65","author":"Y Shidara","year":"2005","unstructured":"Shidara Y, Yamagata K, Kanamori T et al (2005) Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. Cancer Res 65:1655\u20131663","journal-title":"Cancer Res"},{"key":"766_CR40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.200512100","volume":"175","author":"H Pelicano","year":"2006","unstructured":"Pelicano H, Xu RH, Du M et al (2006) Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175:913\u2013923","journal-title":"J Cell Biol"},{"key":"766_CR41","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1737","volume":"5","author":"E Gottlieb","year":"2005","unstructured":"Gottlieb E, Tomlinson IP (2005) Mitochondrial tumour suppressors: a genetic and biochemical update. Nat Rev Cancer 5:857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"766_CR42","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1210\/jc.2002-030008","volume":"88","author":"J Lima","year":"2003","unstructured":"Lima J, Teixeira-Gomes J, Soares P et al (2003) Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia. J Clin Endocrinol Metab 88:4932\u20134937","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR43","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1677\/erc.1.00996","volume":"12","author":"M Montani","year":"2005","unstructured":"Montani M, Schmitt AM, Schmid S et al (2005) No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma. Endocr Relat Cancer 12:1011\u20131016","journal-title":"Endocr Relat Cancer"},{"key":"766_CR44","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1210\/jc.2004-2059","volume":"90","author":"A Cascon","year":"2005","unstructured":"Cascon A, Cebrian A, Pollan M et al (2005) Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 90:2127\u20132130","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR45","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/jnci\/djn254","volume":"100","author":"C Ricketts","year":"2008","unstructured":"Ricketts C, Woodward ER, Killick P et al (2008) Germline SDHB mutations and familial renal cell carcinoma. J Natl Cancer Inst 100:1260\u20131262","journal-title":"J Natl Cancer Inst"},{"key":"766_CR46","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IP Tomlinson","year":"2002","unstructured":"Tomlinson IP, Alam NA, Rowan AJ et al (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"766_CR47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1013","volume":"3","author":"C Eng","year":"2003","unstructured":"Eng C, Kiuru M, Fernandez MJ et al (2003) A role for mitochondrial enzymes in inherited neoplasia and beyond. Nat Rev Cancer 3:193\u2013202","journal-title":"Nat Rev Cancer"},{"key":"766_CR48","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","volume":"14","author":"PJ Pollard","year":"2005","unstructured":"Pollard PJ, Briere JJ, Alam NA et al (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet 14:2231\u20132239","journal-title":"Hum Mol Genet"},{"key":"766_CR49","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.bjc.6602547","volume":"92","author":"V Maximo","year":"2005","unstructured":"Maximo V, Botelho T, Capela J et al (2005) Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer 92:1892\u20131898","journal-title":"Br J Cancer"},{"key":"766_CR50","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1128\/MCB.24.19.8447-8456.2004","volume":"24","author":"G Huang","year":"2004","unstructured":"Huang G, Lu H, Hao A et al (2004) GRIM-19, a cell death regulatory protein, is essential for assembly and function of mitochondrial complex I. Mol Cell Biol 24:8447\u20138456","journal-title":"Mol Cell Biol"},{"key":"766_CR51","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1038\/sj.onc.1209708","volume":"25","author":"I Alchanati","year":"2006","unstructured":"Alchanati I, Nallar SC, Sun P et al (2006) A proteomic analysis reveals the loss of expression of the cell death regulatory gene GRIM-19 in human renal cell carcinomas. Oncogene 25:7138\u20137147","journal-title":"Oncogene"},{"key":"766_CR52","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM (2008) Cancer cell metabolism: Warburg and beyond. Cell 134:703\u2013707","journal-title":"Cell"},{"key":"766_CR53","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1073\/pnas.0502267102","volume":"102","author":"A Ramanathan","year":"2005","unstructured":"Ramanathan A, Wang C, Schreiber SL (2005) Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A 102:5992\u20135997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"766_CR54","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1126863","volume":"312","author":"S Matoba","year":"2006","unstructured":"Matoba S, Kang JG, Patino WD et al (2006) p53 regulates mitochondrial respiration. Science 312:1650\u20131653","journal-title":"Science"},{"key":"766_CR55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin Jr","year":"2008","unstructured":"Kaelin WG Jr, Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30:393\u2013402","journal-title":"Mol Cell"},{"key":"766_CR56","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ (2004) Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4:891\u2013899","journal-title":"Nat Rev Cancer"},{"key":"766_CR57","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1126\/science.1156906","volume":"320","author":"K Ishikawa","year":"2008","unstructured":"Ishikawa K, Takenaga K, Akimoto M et al (2008) ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320:661\u2013664","journal-title":"Science"},{"key":"766_CR58","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1128\/MCB.24.24.10933-10940.2004","volume":"24","author":"JI Piruat","year":"2004","unstructured":"Piruat JI, Pintado CO, Ortega-Saenz P et al (2004) The mitochondrial SDHD gene is required for early embryogenesis, and its partial deficiency results in persistent carotid body glomus cell activation with full responsiveness to hypoxia. Mol Cell Biol 24:10933\u201310940","journal-title":"Mol Cell Biol"},{"key":"766_CR59","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0344-0338(11)80165-2","volume":"188","author":"J Muller-Hocker","year":"1992","unstructured":"Muller-Hocker J (1992) Random cytochrome-C-oxidase deficiency of oxyphil cell nodules in the parathyroid gland. A mitochondrial cytopathy related to cell ageing? Pathol Res Pract 188:701\u2013706","journal-title":"Pathol Res Pract"},{"key":"766_CR60","volume-title":"Tumours of the thyroid gland","author":"J Rosai","year":"1992","unstructured":"Rosai J, Carcangiu ML, DeLellis RA (1992) Tumours of the thyroid gland. Armed Force Institute of Pathology, Washington, DC"},{"key":"766_CR61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/01913128509142147","volume":"8","author":"MA Sobrinho-Simoes","year":"1985","unstructured":"Sobrinho-Simoes MA, Nesland JM, Holm R et al (1985) Hurthle cell and mitochondrion-rich papillary carcinomas of the thyroid gland: an ultrastructural and immunocytochemical study. Ultrastruct Pathol 8:131\u2013142","journal-title":"Ultrastruct Pathol"},{"key":"766_CR62","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/01913128509141518","volume":"8","author":"JM Nesland","year":"1985","unstructured":"Nesland JM, Sobrinho-Simoes MA, Holm R et al (1985) Hurthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269\u2013290","journal-title":"Ultrastruct Pathol"},{"key":"766_CR63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF02899539","volume":"60","author":"D Ebner","year":"1991","unstructured":"Ebner D, Rodel G, Pavenstaedt I et al (1991) Functional and molecular analysis of mitochondria in thyroid oncocytoma. Virchows Arch B Cell Pathol Incl Mol Pathol 60:139\u2013144","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"766_CR64","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/01913129809032263","volume":"22","author":"J Muller-Hocker","year":"1998","unstructured":"Muller-Hocker J, Jacob U, Seibel P (1998) Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4, 977) of mitochondrial DNA. Ultrastruct Pathol 22:91\u2013100","journal-title":"Ultrastruct Pathol"},{"key":"766_CR65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02890014","volume":"56","author":"M Ortmann","year":"1988","unstructured":"Ortmann M, Vierbuchen M, Koller G et al (1988) Renal oncocytoma. I. Cytochrome c oxidase in normal and neoplastic renal tissue as detected by immunohistochemistry\u2014a valuable aid to distinguish oncocytomas from renal cell carcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 56:165\u2013173","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"766_CR66","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s004280000188","volume":"436","author":"J Muller-Hocker","year":"2000","unstructured":"Muller-Hocker J (2000) Expression of bcl-2, Bax and Fas in oxyphil cells of Hashimoto thyroiditis. Virchows Arch 436:602\u2013607","journal-title":"Virchows Arch"},{"key":"766_CR67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0046-8177(96)90158-6","volume":"27","author":"J Muller-Hocker","year":"1996","unstructured":"Muller-Hocker J, Aust D, Napiwotzky J et al (1996) Defects of the respiratory chain in oxyphil and chief cells of the normal parathyroid and in hyperfunction. Hum Pathol 27:532\u2013541","journal-title":"Hum Pathol"},{"key":"766_CR68","first-page":"878","volume":"85","author":"CC Cheung","year":"2000","unstructured":"Cheung CC, Ezzat S, Ramyar L et al (2000) Molecular basis off Hurthle cell papillary thyroid carcinoma. J Clin Endocrinol Metab 85:878\u2013882","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR69","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/106689690501300104","volume":"13","author":"M Sobrinho-Simoes","year":"2005","unstructured":"Sobrinho-Simoes M, Maximo V, Castro IV et al (2005) Hurthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance. Int J Surg Pathol 13:29\u201335","journal-title":"Int J Surg Pathol"},{"key":"766_CR70","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF02176714","volume":"189","author":"T Langhans","year":"1907","unstructured":"Langhans T (1907) \u00dcber die epithelialen Formen der malignen Struma. Virchows Arch 189:69\u2013153","journal-title":"Virchows Arch"},{"key":"766_CR71","unstructured":"DeLellis RA LR, Heitz PU, Eng C (eds) (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of endocrine glands. IARC, Lyon"},{"key":"766_CR72","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/1097-0142(19890315)63:6<1183::AID-CNCR2820630624>3.0.CO;2-3","volume":"63","author":"H Dominguez-Malagon","year":"1989","unstructured":"Dominguez-Malagon H, Delgado-Chavez R, Torres-Najera M et al (1989) Oxyphil and squamous variants of medullary thyroid carcinoma. Cancer 63:1183\u20131188","journal-title":"Cancer"},{"key":"766_CR73","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00428-006-0154-0","volume":"448","author":"M Volante","year":"2006","unstructured":"Volante M, La Rosa S, Castellano I et al (2006) Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas. Virchows Arch 448:545\u2013551","journal-title":"Virchows Arch"},{"key":"766_CR74","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/modpathol.3880085","volume":"13","author":"CA Moran","year":"2000","unstructured":"Moran CA, Suster S (2000) Primary neuroendocrine carcinoma (thymic carcinoid) of the thymus with prominent oncocytic features: a clinicopathologic study of 22 cases. Mod Pathol 13:489\u2013494","journal-title":"Mod Pathol"},{"key":"766_CR75","first-page":"190","volume":"16","author":"ZW Baloch","year":"1999","unstructured":"Baloch ZW, LiVolsi VA (1999) Oncocytic lesions of the neuroendocrine system. Semin Diagn Pathol 16:190\u2013199","journal-title":"Semin Diagn Pathol"},{"key":"766_CR76","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jso.20700","volume":"94","author":"RA DeLellis","year":"2006","unstructured":"DeLellis RA (2006) Pathology and genetics of thyroid carcinoma. J Surg Oncol 94:662\u2013669","journal-title":"J Surg Oncol"},{"key":"766_CR77","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1038\/sj.onc.1206706","volume":"22","author":"P Soares","year":"2003","unstructured":"Soares P, Trovisco V, Rocha AS et al (2003) BRAF mutations and RET\/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene 22:4578\u20134580","journal-title":"Oncogene"},{"key":"766_CR78","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1210\/jc.2005-1336","volume":"91","author":"P Castro","year":"2006","unstructured":"Castro P, Rebocho AP, Soares RJ et al (2006) PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab 91:213\u2013220","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR79","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/path.1511","volume":"202","author":"V Trovisco","year":"2004","unstructured":"Trovisco V, Vieira DCI, Soares P et al (2004) BRAF mutations are associated with some histological types of papillary thyroid carcinoma. J Pathol 202:247\u2013251","journal-title":"J Pathol"},{"key":"766_CR80","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-005-1236-0","volume":"446","author":"V Trovisco","year":"2005","unstructured":"Trovisco V, Soares P, Preto A et al (2005) Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch 446:589\u2013595","journal-title":"Virchows Arch"},{"key":"766_CR81","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/1097-0142(19911101)68:9<1944::AID-CNCR2820680917>3.0.CO;2-I","volume":"68","author":"ML Carcangiu","year":"1991","unstructured":"Carcangiu ML, Bianchi S, Savino D et al (1991) Follicular Hurthle cell tumors of the thyroid gland. Cancer 68:1944\u20131953","journal-title":"Cancer"},{"key":"766_CR82","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1097\/00000478-199812000-00008","volume":"22","author":"HL Evans","year":"1998","unstructured":"Evans HL, Vassilopoulou-Sellin R (1998) Follicular and Hurthle cell carcinomas of the thyroid: a comparative study. Am J Surg Pathol 22:1512\u20131520","journal-title":"Am J Surg Pathol"},{"key":"766_CR83","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0039-6060(96)80046-8","volume":"120","author":"MP McDonald","year":"1996","unstructured":"McDonald MP, Sanders LE, Silverman ML et al (1996) Hurthle cell carcinoma of the thyroid gland: prognostic factors and results of surgical treatment. Surgery 120:1000\u20131004","journal-title":"Surgery"},{"key":"766_CR84","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00000478-199303000-00010","volume":"17","author":"M Papotti","year":"1993","unstructured":"Papotti M, Botto Micca F, Favero A et al (1993) Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol 17:291\u2013301","journal-title":"Am J Surg Pathol"},{"key":"766_CR85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0025-6196(12)65621-3","volume":"59","author":"RG Watson","year":"1984","unstructured":"Watson RG, Brennan MD, Goellner JR et al (1984) Invasive Hurthle cell carcinoma of the thyroid: natural history and management. Mayo Clin Proc 59:851\u2013855","journal-title":"Mayo Clin Proc"},{"key":"766_CR86","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000478-198604000-00003","volume":"10","author":"W Lang","year":"1986","unstructured":"Lang W, Choritz H, Hundeshagen H (1986) Risk factors in follicular thyroid carcinomas. A retrospective follow-up study covering a 14-year period with emphasis on morphological findings. Am J Surg Pathol 10:246\u2013255","journal-title":"Am J Surg Pathol"},{"key":"766_CR87","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/jcem-39-4-719","volume":"39","author":"LJ Valenta","year":"1974","unstructured":"Valenta LJ, Michel-Bechet M, Warshaw JB et al (1974) Human thyroid tumors composed of mitochondrion-rich cells: electron microscopic and biochemical findings. J Clin Endocrinol Metab 39:719\u2013733","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR88","first-page":"103","volume-title":"Endocrine pathology","author":"RL Apel","year":"2002","unstructured":"Apel RL, Asa SL (2002) The parathyroid glands. In: LiVolsi V, Asa SL (eds) Endocrine pathology. Churchill Livingstone, Philadelphia, pp 103\u2013137"},{"key":"766_CR89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/dc.20115","volume":"31","author":"T Giorgadze","year":"2004","unstructured":"Giorgadze T, Stratton B, Baloch ZW et al (2004) Oncocytic parathyroid adenoma: problem in cytological diagnosis. Diagn Cytopathol 31:276\u2013280","journal-title":"Diagn Cytopathol"},{"key":"766_CR90","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00000478-200203000-00008","volume":"26","author":"LA Erickson","year":"2002","unstructured":"Erickson LA, Jin L, Papotti M et al (2002) Oxyphil parathyroid carcinomas: a clinicopathologic and immunohistochemical study of 10 cases. Am J Surg Pathol 26:344\u2013349","journal-title":"Am J Surg Pathol"},{"key":"766_CR91","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1288\/00005537-199407000-00004","volume":"104","author":"GH Yoo","year":"1994","unstructured":"Yoo GH, Eisele DW, Askin FB et al (1994) Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope 104:799\u2013803","journal-title":"Laryngoscope"},{"key":"766_CR92","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0046-8177(00)80007-6","volume":"31","author":"K Honda","year":"2000","unstructured":"Honda K, Kashima K, Daa T et al (2000) Clonal analysis of the epithelial component of Warthin's tumor. Hum Pathol 31:1377\u20131380","journal-title":"Hum Pathol"},{"key":"766_CR93","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0002-9610(05)80725-1","volume":"164","author":"CA Kotwall","year":"1992","unstructured":"Kotwall CA (1992) Smoking as an etiologic factor in the development of Warthin's tumor of the parotid gland. Am J Surg 164:646\u2013647","journal-title":"Am J Surg"},{"key":"766_CR94","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-5347(05)68259-6","volume":"162","author":"NR Zambrano","year":"1999","unstructured":"Zambrano NR, Lubensky IA, Merino MJ et al (1999) Histopathology and molecular genetics of renal tumors toward unification of a classification system. J Urol 162:1246\u20131258","journal-title":"J Urol"},{"key":"766_CR95","first-page":"935","volume":"18","author":"N Kuroda","year":"2003","unstructured":"Kuroda N, Toi M, Hiroi M et al (2003) Review of renal oncocytoma with focus on clinical and pathobiological aspects. Histol Histopathol 18:935\u2013942","journal-title":"Histol Histopathol"},{"key":"766_CR96","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/01913129809033479","volume":"22","author":"V Maximo","year":"1998","unstructured":"Maximo V, Soares P, Rocha AS et al (1998) The common deletion of mitochondrial DNA is found in goiters and thyroid tumors with and without oxyphil cell change. Ultrastruct Pathol 22:271\u2013273","journal-title":"Ultrastruct Pathol"},{"key":"766_CR97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/1096-9896(200012)192:4<561::AID-PATH790>3.0.CO;2-3","volume":"192","author":"V Maximo","year":"2000","unstructured":"Maximo V, Sobrinho-Simoes M (2000) Mitochondrial DNA \u2018common\u2019 deletion in Hurthle cell lesions of the thyroid. J Pathol 192:561\u2013562","journal-title":"J Pathol"},{"key":"766_CR98","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0925-4439(95)00034-2","volume":"1271","author":"G Attardi","year":"1995","unstructured":"Attardi G, Yoneda M, Chomyn A (1995) Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems. Biochim Biophys Acta 1271:241\u2013248","journal-title":"Biochim Biophys Acta"},{"key":"766_CR99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0925-4439(96)00026-9","volume":"1316","author":"A Heddi","year":"1996","unstructured":"Heddi A, Faure-Vigny H, Wallace DC et al (1996) Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim Biophys Acta 1316:203\u2013209","journal-title":"Biochim Biophys Acta"},{"key":"766_CR100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/gcc.2870010112","volume":"1","author":"C Welter","year":"1989","unstructured":"Welter C, Kovacs G, Seitz G et al (1989) Alteration of mitochondrial DNA in human oncocytomas. Genes Chromosomes Cancer 1:79\u201382","journal-title":"Genes Chromosomes Cancer"},{"key":"766_CR101","first-page":"1","volume":"3","author":"JD Brooks","year":"1999","unstructured":"Brooks JD, Marshall FF, Isaacs WB et al (1999) Absence of HinfI restriction abnormalities in renal oncocytoma mitochondrial DNA. Mol Urol 3:1\u20133","journal-title":"Mol Urol"},{"key":"766_CR102","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/carcin\/23.5.759","volume":"23","author":"H Simonnet","year":"2002","unstructured":"Simonnet H, Alazard N, Pfeiffer K et al (2002) Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23:759\u2013768","journal-title":"Carcinogenesis"},{"key":"766_CR103","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/carcin\/bgg109","volume":"24","author":"H Simonnet","year":"2003","unstructured":"Simonnet H, Demont J, Pfeiffer K et al (2003) Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis 24:1461\u20131466","journal-title":"Carcinogenesis"},{"key":"766_CR104","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1158\/1078-0432.CCR-07-4131","volume":"14","author":"JA Mayr","year":"2008","unstructured":"Mayr JA, Meierhofer D, Zimmermann F et al (2008) Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res 14:2270\u20132275","journal-title":"Clin Cancer Res"},{"key":"766_CR105","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/10507250152039055","volume":"11","author":"F Savagner","year":"2001","unstructured":"Savagner F, Chevrollier A, Loiseau D et al (2001) Mitochondrial activity in XTC.UC1 cells derived from thyroid oncocytoma. Thyroid 11:327\u2013333","journal-title":"Thyroid"},{"key":"766_CR106","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1210\/jc.2003-031238","volume":"89","author":"O Baris","year":"2004","unstructured":"Baris O, Savagner F, Nasser V et al (2004) Transcriptional profiling reveals coordinated up-regulation of oxidative metabolism genes in thyroid oncocytic tumors. J Clin Endocrinol Metab 89:994\u20131005","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR107","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1210\/jc.2004-1337","volume":"90","author":"C Jacques","year":"2005","unstructured":"Jacques C, Baris O, Prunier-Mirebeau D et al (2005) Two-step differential expression analysis reveals a new set of genes involved in thyroid oncocytic tumors. J Clin Endocrinol Metab 90:2314\u20132320","journal-title":"J Clin Endocrinol Metab"},{"key":"766_CR108","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2407-4-12","volume":"4","author":"V Maximo","year":"2004","unstructured":"Maximo V, Preto A, Crespo A et al (2004) Core I gene is overexpressed in Hurthle and non-Hurthle cell microfollicular adenomas and follicular carcinomas of the thyroid. BMC Cancer 4:12","journal-title":"BMC Cancer"},{"key":"766_CR109","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00428-005-0065-5","volume":"447","author":"M Sobrinho-Simoes","year":"2005","unstructured":"Sobrinho-Simoes M, Preto A, Rocha AS et al (2005) Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch 447:787\u2013793","journal-title":"Virchows Arch"},{"key":"766_CR110","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10863-007-9094-x","volume":"39","author":"PL Pedersen","year":"2007","unstructured":"Pedersen PL (2007) Warburg, me and Hexokinase 2: multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the \u201cWarburg effect\u201d, i.e., elevated glycolysis in the presence of oxygen. J Bioenerg Biomembr 39:211\u2013222","journal-title":"J Bioenerg Biomembr"},{"key":"766_CR111","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3835(01)00667-X","volume":"173","author":"YH Ko","year":"2001","unstructured":"Ko YH, Pedersen PL, Geschwind JF (2001) Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. Cancer Lett 173:83\u201391","journal-title":"Cancer Lett"},{"key":"766_CR112","first-page":"3909","volume":"62","author":"JF Geschwind","year":"2002","unstructured":"Geschwind JF, Ko YH, Torbenson MS et al (2002) Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer Res 62:3909\u20133913","journal-title":"Cancer Res"},{"key":"766_CR113","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","volume":"11","author":"S Bonnet","year":"2007","unstructured":"Bonnet S, Archer SL, Allalunis-Turner J et al (2007) A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 11:37\u201351","journal-title":"Cancer Cell"},{"key":"766_CR114","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","volume":"124","author":"O Warburg","year":"1956","unstructured":"Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269\u2013270","journal-title":"Science"},{"key":"766_CR115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyssegur","year":"2006","unstructured":"Pouyssegur J, Dayan F, Mazure NM (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437\u2013443","journal-title":"Nature"},{"key":"766_CR116","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nrc2344","volume":"8","author":"RG Bristow","year":"2008","unstructured":"Bristow RG, Hill RP (2008) Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 8:180\u2013192","journal-title":"Nat Rev Cancer"},{"key":"766_CR117","first-page":"3810","volume":"117","author":"DF Higgins","year":"2007","unstructured":"Higgins DF, Kimura K, Bernhardt WM et al (2007) Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 117:3810\u20133820","journal-title":"J Clin Invest"},{"key":"766_CR118","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH, Wu MZ, Chiou SH et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295\u2013305","journal-title":"Nat Cell Biol"},{"key":"766_CR119","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1056\/NEJMra0805239","volume":"359","author":"AC Chiang","year":"2008","unstructured":"Chiang AC, Massague J (2008) Molecular basis of metastasis. N Engl J Med 359:2814\u20132823","journal-title":"N Engl J Med"},{"key":"766_CR120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","volume":"7","author":"MA Selak","year":"2005","unstructured":"Selak MA, Armour SM, MacKenzie ED et al (2005) Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7:77\u201385","journal-title":"Cancer Cell"},{"key":"766_CR121","unstructured":"MITOMAP (2007) A human mitochondrial genome database www.mitomap.org ."}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-009-0766-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-009-0766-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T08:56:28Z","timestamp":1710233788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-009-0766-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,3]]},"references-count":121,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["766"],"URL":"https:\/\/doi.org\/10.1007\/s00428-009-0766-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,3]]}}}